07 Nov 2024
Millennium opts for pharma, offers guaranteed coupon
The Polish commercial bank’s latest public offer promises a guaranteed return of at least 4.80% after two years.
28 Oct 2024
SRP in brief: allez, allez, allez
Interest linked structured products came out on top in the French market during the first nine months of 2024, according to SRP research.
25 Oct 2024
Product wrap: Goldman puts luxury goods, pharmaceuticals in focus
In this week’s wrap we look at a selection of structured products with strike dates between 20-26 October 2024.
20 Apr 2021
Product snapshot: RCB offers 10% coupon on US vaccine basket
The Austrian structured product house has launched a reverse convertible on a worst of basket of three pharma stocks.
24 Mar 2021
Pharma in structured products (part 3) – performance and underlying analysis
In the third part of our analysis, we look at the markets that saw the best performance for pharma products during 2020 as well as modern portfolio theory (MPT) considerations and its deficiencies when applied to the structured product ecosystem.
23 Mar 2021
Pharma in structured products (part 2) - stagnating issuance in main pharma markets
Buoyant issuance in Malaysia, Belgium and France; reverse convertibles linked to pharma companies have been less affected than growth products, notably the leverage long with stop loss; US breakdown – CVS Health losing ground in sales, Merck records sustained growth.
22 Mar 2021
Pharma in structured products - issuance & sales
Underlying analysis of pharma-based structured products amid a challenging economic climate shows falling sales and issuance.